| Serial Number | 87278810 |
| Word Mark | T |
| Filing Date | Thursday, December 22, 2016 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 10, 2019 |
| Registration Number | 5857855 |
| Registration Date | Tuesday, September 10, 2019 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, May 30, 2017 |
| Description of Mark | The mark consists of a stylized letter "T" with the top left half in the color red, forming the left edge of a triangle that is red with a dot in the middle in the color white and that includes within it the top right and bottom of the letter "T" in white. |
| Goods and Services | Pharmaceuticals, namely, treatment for central nervous disorders, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; implantable delivery systems comprised of sustainable release drugs for treatment for central nervous disorders and other serious and life-threatening diseases, cancer, hematological disorders, endocrine disorders, metabolic disorders, inflammatory disorders, gastrointestinal disorders, liver disease, heart disorders, lung and bronchial disease, blood cardiovascular disease, circulatory system disease, intestinal disorders, bone disease, autoimmune disorders and disorders of the immune systems, infectious disease and enzyme deficiency disease; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases |
| Indication of Colors claimed | The color(s) red and white is/are claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 6, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, February 26, 2019 |
| First Use In Commerce Date | Tuesday, February 26, 2019 |
| Party Name | Titan Pharmaceuticals, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Party Name | Titan Pharmaceuticals, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Party Name | Titan Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Event Date | Event Description |
| Wednesday, March 22, 2017 | ASSIGNED TO EXAMINER |
| Tuesday, December 27, 2016 | NEW APPLICATION ENTERED |
| Friday, January 6, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, January 7, 2017 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, March 28, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, March 28, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, March 28, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Saturday, January 20, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, March 28, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, March 28, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 10, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 30, 2017 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 30, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 25, 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, January 18, 2018 | SOU TEAS EXTENSION RECEIVED |
| Thursday, January 18, 2018 | SOU EXTENSION 1 FILED |
| Thursday, January 18, 2018 | SOU EXTENSION 1 GRANTED |
| Tuesday, July 9, 2019 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, March 28, 2018 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Wednesday, June 27, 2018 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, June 27, 2018 | SOU EXTENSION 2 FILED |
| Wednesday, June 27, 2018 | SOU EXTENSION 2 GRANTED |
| Friday, June 29, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, January 16, 2019 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, January 16, 2019 | SOU EXTENSION 3 FILED |
| Wednesday, January 16, 2019 | SOU EXTENSION 3 GRANTED |
| Friday, January 18, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, July 9, 2019 | USE AMENDMENT FILED |
| Monday, July 29, 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, July 30, 2019 | STATEMENT OF USE PROCESSING COMPLETE |
| Friday, August 2, 2019 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, September 10, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, September 10, 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Saturday, August 3, 2019 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |